Virtu Financial LLC Ptc Therapeutics, Inc. Transaction History

Virtu Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	SELL	$18.07 - $29.37 $48,590 - $78,975	-2,689 Reduced 22.58%	9,222 $254,000
Q3 2023 Nov 14, 2023	BUY	$22.41 - $41.99 $266,925 - $500,142	11,911 New	11,911 $267,000
Q2 2022 Aug 09, 2022	BUY	$25.6 - $45.23 $168,678 - $298,020	6,589 New	6,589 $264,000
Q1 2021 May 19, 2021	SELL	$46.8 - $68.92 $391,154 - $576,033	-8,358 Closed	0 $0
Q4 2020 Feb 24, 2021	SELL	$47.96 - $67.64 $28,056 - $39,569	-585 Reduced 6.54%	8,358 $510,000
Q1 2018 May 14, 2018	SELL	$17.46 - $32.59 $102,333 - $191,009	-5,861 Reduced 39.59%	8,943 $242,000
Q4 2017 Feb 09, 2018	BUY	$15.14 - $20.89 $224,132 - $309,255	14,804	14,804 $247,000

215

79.2M

122K

212K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.69B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.